17 June 2026 Press releases

GvW is advising the seller of the Rabenstein Clinic on its sale to VITREA

GvW Graf von Westphalen advised Thomas Bruschinsky, the former owner and managing director of the Rabenstein Clinic, on the sale of the clinic to the VITREA Group. Following the notarisation of the sale at the end of 2025, the transaction has now been finalised. With this transaction, VITREA – Europe’s third-largest provider of rehabilitation services – is further expanding its presence in the German rehabilitation market.

The Rabenstein Clinic, based in the Hessian town of Bad Salzhausen, has 180 beds and employs around 190 employees. Its medical specialisms lie in the fields of orthopaedics and internal medicine. In addition, the clinic offers specialised rehabilitation programmes, including those for obesity, medically and vocationally oriented rehabilitation (MBOR) and behavioural medicine-based orthopaedic rehabilitation (VMO). Thomas Bruschinsky took over the clinic 34 years ago and developed it into a well-established rehabilitation facility.

With more than 70 inpatient and outpatient facilities in Germany, Austria and Switzerland, VITREA is one of Europe’s leading rehabilitation providers. In Germany, the group operates 27 rehabilitation clinics, two acute care hospitals, eight outpatient rehabilitation centres, two medical care centres, nine care homes, as well as other healthcare and prevention services.

GvW advised the seller on this transaction with a team comprising Dr Marco Zessel (lead), Alexander Stefan Metz, Jan Hüniken (all Corporate/M&A), Dr Peter Trösser (Healthcare & Life Sciences), Sven-Erik Holm (IT/Data Protection), Christian Kusulis (Competition Law), Andrea Torka, Alina Sturm (both Property Law), Nicolas M. Dumont (IP) and Karsten Kujath (Employment Law).

Stay informed

You don't want to miss any more of the latest legal developments? And be invited to our events? Then register here.